APA (7th ed.) Citation

Hashimoto, T., Yoshida, K., Yokoyama, Y., Hashimoto, N., Kaneshiro, K., Yoshikawa, T., . . . Hashiramoto, A. (2023). Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis. Clinical & Experimental Immunology, 213(2), 209. https://doi.org/10.1093/cei/uxad064

Chicago Style (17th ed.) Citation

Hashimoto, Teppei, et al. "Tocilizumab Suppresses NF-kappa B Activation via Toll-like Receptor 9 Signaling by Reducing Cell-free DNA in Rheumatoid Arthritis." Clinical & Experimental Immunology 213, no. 2 (2023): 209. https://doi.org/10.1093/cei/uxad064.

MLA (9th ed.) Citation

Hashimoto, Teppei, et al. "Tocilizumab Suppresses NF-kappa B Activation via Toll-like Receptor 9 Signaling by Reducing Cell-free DNA in Rheumatoid Arthritis." Clinical & Experimental Immunology, vol. 213, no. 2, 2023, p. 209, https://doi.org/10.1093/cei/uxad064.